Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole

Arthritis and Rheumatism
K de GrootW L Gross

Abstract

To compare the efficacy of low-dose intravenous (IV) methotrexate (MTX; 0.3 mg/kg once weekly), both with and without concomitant prednisone, versus daily oral trimethoprim/sulfamethoxazole (T/S; 160 mg of trimethoprim + 800 mg of sulfamethoxazole twice a day), with and without prednisone, in maintaining remission in patients with generalized Wegener's granulomatosis (WG). In this study, 65 patients with generalized WG whose disease had entered remission with cyclophosphamide (CYC) and prednisone therapy were started on one of the following remission-maintenance regimens: MTX alone (group A; n = 22), T/S alone (group B; n = 24), MTX plus concomitant prednisone (group C; n = 11), and T/S plus concomitant prednisone (group D; n = 8). Clinical, radiographic, and seroimmunologic data were evaluated to assess the efficacy of the 4 regimens and to seek possible predictive factors concerning outcome in each group. Partial or complete remission was maintained in 86% of the patients in group A, but in only 58% of those in group B (P < 0.05). In group C, 91% of patients remained in remission, which is in sharp contrast to group D, in which all patients experienced a relapse after a median of 14.5 months (P < 0.005). Side effects occurred...Continue Reading

References

Sep 1, 1975·Arthritis and Rheumatism·M J RezaC M Pearson
Nov 1, 1992·Arthritis and Rheumatism·G S HoffmanA S Fauci
Jul 1, 1992·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·R AsmusA Beigel
Mar 15, 1992·Annals of Internal Medicine·G S HoffmanA S Fauci
Jul 1, 1989·Annals of Internal Medicine·B NölleW L Gross
May 1, 1989·Cleveland Clinic Journal of Medicine·P L KrallW S Wilke
Sep 27, 1980·British Medical Journal·A J PinchingD K Peters
Dec 1, 1994·QJM : Monthly Journal of the Association of Physicians·J W Paulley
Apr 1, 1994·Arthritis and Rheumatism·G S HoffmanA S Fauci
Jan 1, 1994·Rheumatology International·A SchnabelW L Gross
Feb 1, 1994·Arthritis and Rheumatism·J C JennetteC G Kallenberg
Mar 1, 1993·Clinical and Experimental Immunology·C A StegemanC G Kallenberg
Jan 1, 1996·QJM : Monthly Journal of the Association of Physicians·E Reinhold-KellerW L Gross

❮ Previous
Next ❯

Citations

Jul 18, 2001·Springer Seminars in Immunopathology·D Carruthers, P Bacon
Oct 10, 2001·Springer Seminars in Immunopathology·D Jayne
Oct 20, 2009·Zeitschrift für Rheumatologie·C Fiehn
Sep 10, 2011·Current Rheumatology Reports·Antonio Iglesias-GamarraLuis R Espinoza
Jan 25, 2012·Current Treatment Options in Cardiovascular Medicine·Carol A Langford
Nov 30, 2000·Current Treatment Options in Neurology·S Zivkovic, P M Moore
Dec 20, 2002·Clinics in Dermatology·Andreas Katsambas, Panagiota Riga
Jan 13, 2000·Clinics in Dermatology·L AtzoriP Biggio
Jan 13, 2000·Clinics in Dermatology·G A Vena, N Cassano
Sep 15, 2001·European Journal of Internal Medicine·L Guillevin
Jul 25, 2003·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Elizabeth S PausJenssen, Donald W Cockcroft
Jun 8, 2001·Joint, Bone, Spine : Revue Du Rhumatisme·V FoltzB Fautrel
Nov 20, 1997·The New England Journal of Medicine·J C Jennette, R J Falk
Jul 4, 2003·The New England Journal of Medicine·David JayneUNKNOWN European Vasculitis Study Group
Dec 26, 2008·The New England Journal of Medicine·Christian PagnouxUNKNOWN French Vasculitis Study Group
Feb 27, 2001·Current Opinion in Nephrology and Hypertension·J W TervaertC G Kallenberg
Dec 14, 2005·Current Opinion in Rheumatology·Bernhard HellmichWolfgang L Gross
Feb 25, 2011·Current Opinion in Rheumatology·Cees G M Kallenberg
May 8, 2007·Current Opinion in Otolaryngology & Head and Neck Surgery·Vanessa R Erickson, Peter H Hwang
Jan 12, 2000·Australian and New Zealand Journal of Medicine·P A Gatenby
Jun 22, 1999·Thorax·C A Langford, G S Hoffman
Nov 6, 2009·Arthritis Research & Therapy·Frank MoosigWolfgang L Gross
Feb 10, 2009·Der Internist·F MoosigUNKNOWN European League Against Rheumatism (EULAR)
Jul 1, 2008·Expert Review of Clinical Immunology·R MannaG Paludetti
May 19, 2009·Expert Opinion on Pharmacotherapy·Marian Chan, Raashid Luqmani
Jan 5, 2002·Expert Opinion on Investigational Drugs·C Thomas-Golbanov, S Sridharan
Feb 16, 2006·Chest·Stephen K FrankelKevin K Brown
Jun 21, 2011·Annales de cardiologie et d'angéiologie·S LeroyP Seve
Aug 7, 2010·Rheumatic Diseases Clinics of North America·Julia U HolleWolfgang L Gross
Aug 10, 2010·Clinics in Chest Medicine·Keith C MeyerRobert Baughman
Nov 26, 2009·Neurologic Clinics·Alireza MinagarStephen L Jaffe
Jun 11, 2009·Best Practice & Research. Clinical Rheumatology·David Carruthers, Jonathan Sherlock
May 1, 2010·Reumatología clinica·Iñigo Rúa-Figueroa Fernández de Larrinoa, Celia Erausquin Arruabarrena
Apr 7, 2009·Journal of Autoimmunity·J U Holle, W L Gross
Oct 27, 2015·Chest·Timothy J Vece, Lisa R Young
Mar 17, 2007·La Presse médicale·Christian Pagnoux, Luis Teixeira
Feb 12, 2004·Arthritis and Rheumatism·Dominique BlignyLoïc Guillevin
Jun 1, 2001·Acta Clinica Belgica·L Guillevin
May 6, 2008·The American Journal of Medicine·Justin M BachmannJoshua T Schiffer
Jul 27, 2001·Best Practice & Research. Clinical Rheumatology·C A Langford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.